Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
glaxosmithkline
4
×
life sciences
national blog main
new york blog main
new york top stories
4
×
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
biogen
biotech
clinical trials
gene therapy
merck
national
national top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
adverum biotechnologies
alzheimer's disease
amgen
bausch health
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
breast cancer
bristol-myers squibb
cancer immunotherapy
deals
detroit blog main
detroit top stories
diagnostics
What
drug
4
×
bio
roundup
companies
pfizer
acquisitions
activity
advanced
albert
approval
arrival
award
biggest
biogen’s
biopharmaceutical
biotech
bourla
cancer
ceo
company
convo
crispr
data
days
death
decades
dems
dog
earlier
failures
firm
future
given
hasn’t
immunotherapy
imports
ipo
ipos
leading
line
Language
unset
unknown
Current search:
glaxosmithkline
×
drug
×
" new york top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More